"Development of the proteasome inhibitor Velcade™ (bortezomib)" by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D.

Research output: Contribution to journalArticle

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)328-329
Number of pages2
JournalCancer Investigation
Volume22
Issue number2
StatePublished - 2004

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this